MFN News
Language
01 Nov, 2022
Boule Diagnostics AB: Kommuniké från Boule Diagnostics extra bolagsstämma den 1 november 2022
News
Swedish
Regulatory
IR
Boule Diagnostics AB ("Boule") har idag den 1 november 2022 hållit en extra bolagsstämma. De fullständiga förslagen till beslut har tidigare publicerats...
28 Oct, 2022
Boule Diagnostics AB: Boule Diagnostics - Valberedning inför årsstämman 2023
News
Swedish
IR
Årsstämman 2022 i Boule Diagnostics AB (publ), ("Boule"), beslutade att en valberedning baserad på ägarförhållandena den 30 september 2022 ska utses...
Årsstämman 2022 i Boule Diagnostics AB (publ), (”Boule”), beslutade att en valberedning baserad på ägarförhållandena den 30 september 2022 ska...
20 Oct, 2022
Boule Diagnostics AB: Boule startar kontraktstillverkning av reagens i Indien
News
Swedish
IR
Boule Diagnostics har tecknat ett strategiskt kontraktstillverkningsavtal med Q-Line Biotech för lokal tillverkning av hematologireagens i Indien. Indien...
Boule Diagnostics har tecknat ett strategiskt kontraktstillverkningsavtal med Q-Line Biotech för lokal tillverkning av hematologireagens i Indien. Indien...
03 Oct, 2022
Boule Diagnostics AB: KALLELSE TILL EXTRA BOLAGSSTÄMMA I BOULE DIAGNOSTICS AB
News
Swedish
Regulatory
IR
Aktieägarna i Boule Diagnostics AB, org.nr 556535-0252 ("Bolaget"), kallas härmed till extra bolagsstämma tisdag den 1 november 2022 kl. 16.00 på Domnarvsgatan...
Aktieägarna i Boule Diagnostics AB, org.nr 556535-0252 (”Bolaget”), kallas härmed till extra bolagsstämma tisdag den 1 november 2022 kl. 16.00 på...
03 Oct, 2022
Boule Diagnostics AB: Boule Diagnostics beslutar om en fullt säkerställd företrädesemission om cirka 150 MSEK
News
Swedish
Regulatory
IR
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, BELARUS, HONGKONG, JAPAN, KANADA, NYA ZEELAND...
03 Oct, 2022
Boule Diagnostics beslutar om en fullt säkerställd företrädesemission om cirka 150 MSEK
News
Swedish
Regulatory
MAR
IR
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, BELARUS, HONGKONG, JAPAN, KANADA, NYA ZEELAND...
06 Sep, 2022
Boule Diagnostics AB: Clinical Diagnostic Solutions har mottagit observationer från amerikanska myndigheten FDA
News
Swedish
IR
Clinical Diagnostic Solutions, Inc. (CDS), ett dotterbolag till Boule Diagnostics AB, har mottagit observationer från USA:s livsmedels- och läkemedelsmyndighet...
06 Sep, 2022
Clinical Diagnostic Solutions har mottagit observationer från amerikanska myndigheten FDA
News
Swedish
IR
Clinical Diagnostic Solutions, Inc. (CDS), ett dotterbolag till Boule Diagnostics AB, har mottagit observationer från USA:s livsmedels- och läkemedelsmyndighet...
04 Aug, 2022
Boule Diagnostics AB: CFO Annette Colin lämnar Boule av familjeskäl
News
Swedish
Regulatory
IR
Annette Colin har idag informerat att hon lämnar posten som CFO för Boule Diagnostics på grund av familjeskäl. Annette kommer fortsätta i sin roll...
21 Oct, 2019
Boule Diagnostics – Nomination Committee for the 2020 Annual General Meeting
News
English
IR
The Annual General Meeting, (”AGM”), 2019 of Boule Diagnostics AB (publ), (”Boule”), decided that a Nomination Committee based on the ownership...
14 Aug, 2019
Boule Diagnostics AB (publ) Interim report January–June 2019
News
English
Regulatory
MAR
VPML
Report
Interim
Q2
IR
The trend of strong growth in sales continues In connection with changes in the distributor structure in Russia, a credit risk has been identified...
Boule Diagnostics AB will publish the interim report for the period January – June 2019 at 15:00, Wednesday August 14, 2019. Following the publication...
22 Jul, 2019
Fredrik Dalborg leaves the position as CEO of Boule Diagnostics AB
News
English
Regulatory
MAR
IR
Fredrik Dalborg, CEO and Group President of Boule Diagnostics, has decided to leave the company and continue his career with new assignments outside the...
06 May, 2019
Bulletin from Annual General Meeting in Boule Diagnostics AB on May 6, 2019
News
English
IR
The Annual General Meeting (the ”AGM”) decided to adopt the balance sheet, income statement, consolidated income statement and consolidated balance...
06 May, 2019
Boule Diagnostics AB (publ) Interim report January–March 2019
News
English
Regulatory
MAR
Report
Interim
Q1
IR
2019 starts off with a strong growth in sales Significant events during the quarter No significant events occured in the first quarter 2019. Significant...
Boule Diagnostics AB will publish the interim report for the period January – March 2019 at 15:00, Monday May 6, 2019. Following the publication, Boule...
15 Apr, 2019
Boule Diagnostics publishes the annual report for 2018
News
English
Regulatory
VPML
Report
Annual
IR
Boule Diagnostics AB has published the full annual report for the fiscal year 2018 at www.boule.com. The annual report is available in Swedish below...
07 Feb, 2019
Boule Diagnostics AB (publ) Year-end report January – December 2018
News
English
Regulatory
MAR
Report
Interim
Yearend
IR
Good sales of instruments, product and geographic mix resulted in low margins Warning letter received from the FDA Following a routine inspection of...
Boule Diagnostics AB will publish the year-end report for the period January – December 2018 at 15:00, Thursday February 7, 2019. Following the publication...
18 Dec, 2018
Boule Diagnostics – Information regarding the investment in the strategic near patient diagnostics partnership
News
English
IR
Boule Diagnostics AB will hold a conference call to inform about the strategic partnership Boule has entered with the diagnostics company, biosurfit. CEO...
14 Dec, 2018
Boule Diagnostics invests in strategic near patient diagnostics partnership
News
English
Regulatory
MAR
IR
Boule has entered a strategic partnership, investing EUR 5 million in the diagnostic company biosurfit. The partnership is in alignment with the established...